Pulmonary functional assessment: longitudinal study after treatment of pulmonary tuberculosis

Rev Inst Med Trop Sao Paulo. 2021 Aug 16:63:e65. doi: 10.1590/S1678-9946202163065. eCollection 2021.

Abstract

Even when treated adequately, pulmonary tuberculosis can lead to pulmonary sequelae. Patients treated for PTB between 2012 and 2016 answered a standardized questionnaire and underwent chest radiography and spirometry, measurement of absolute pulmonary volume, Diffusing Capacity for Carbon Monoxide (DLCO) and the 6-min walk test (6MWT) on two occasions: within the first year after the end of treatment (follow-up 1), and one and two years after follow-up 1 (follow-up 2). A total of 55 patients they underwent spirometry, 23 (41.82%) had obstructive ventilatory disorder (OVD) and eight (14.5%) had moderate OVD. In total, 29 patients underwent pulmonary function tests (PFTs) and 24 patients underwent the 6MWT on two occasions. The functional changes after PTB treatment appear not to have varied between one and two years of follow-up. There was a correlation between low FEV1 and low DLCO (p<0.001); low DLCO and low 6MWT (p<0.001) and radiographic abnormalities and low FEV1 (p=0.033). The most frequently observed change in spirometry was found in patients with OVD.

MeSH terms

  • Forced Expiratory Volume
  • Humans
  • Longitudinal Studies
  • Pulmonary Diffusing Capacity
  • Pulmonary Disease, Chronic Obstructive*
  • Tuberculosis, Pulmonary* / drug therapy